In the third announcement about cell and gene manufacturing within the week, Belgium-based Masthercell Global says it will build out a commercial-scale facility in its home country. More: Masthercell adds to global gene and cell manufacturing frenzy with EU facility
read moreFacing a long list of opioid mismarketing lawsuits, Purdue has agreed to its first settlement, according to numerous anonymously sourced media reports. Oklahoma’s attorney general Mike Hunter is expected to announce the deal Tuesday afternoon. More: As Purdue settles first
read moreSanofi has said that it could potentially airlift its flu vaccine into the UK in the event of a no-deal Brexit. More: Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event Source: News
read moreThe drug is the first oral medicine approved in Europe as an adjunct to insulin for adults with type I diabetes. More: EU approves AZ' Forxiga for type I diabetes Source: News
read moreMotif Bio has announced that it has raised £2.7 million from a share placing, to provide additional working capital. More: Motif Bio raises £2.7 million via share placing Source: News
read moreTiziana has submitted an Investigational New Drug application for an oral formulation of Foralumab. More: Tiziana submits IND for Foralumab oral formulation in NASH Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals